Skip to main content
. 2019 Oct 21;102(1):78–89. doi: 10.4269/ajtmh.19-0436

Table 1.

Demographics of racemose disease

Median (range)
Parameter
 Total with racemose disease 34
  Active disease 30
  Inactive (calcified) disease 4
 Male (%) 58.8
 Hispanic (%) 82.4
 Travel related (%) 5.9
Age parameters (years)
 At enrollment, n = 34 37.9 (66–25)
 At diagnosis, n = 34 35.6 (16.4–66.2)
 At initial symptoms occurred, n = 34 29.7 (4–64.1)
  Patients who did not revisit endemic regions, n = 17 24.3 (7.7–46.2)
 At immigration, n = 30 24.5 (7.7–49.3)
Time parameters (years)
 Duration from immigration to symptoms (n = 27) 10.0 (2–25.6)
   Patients who did not revisit endemic regions n = 17) 10.0 (0.18–25.6)
 Duration of symptoms before immigration (n = 4) −5.0 (2–9.5)
 Duration from immigration to diagnosis (n = 30) 12.8 (1–33.6)
   Patients who did not revisit endemic regions (n = 22) 10.3 (1–27.0)
 Duration followed up at the NIH 5.3 (0.2–33.2)
 Duration from end of cysticidal treatment (n = 28) 4.2 (0.2–18.1)
 Duration of disease since diagnosis, including follow-up* 8.3 (0.01–39.9)

* From diagnosis to last NIH visit.